Charity profile · Historical source record

CurePSP

EIN 52-1704978HealthNew YorkSmall

Historical collection: May 2019 · Rating details mostly from 2017. Source & context

The mission

What this organization describes

because hope matters
CurePSP, Inc. is dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and related brain diseases; advancing research toward cure and prevention; educating healthcare professionals; and providing support, education and hope for affected persons and their families. PSP and CBD are neurodegenerative brain diseases that have no known cause, treatment or cure. They affect nerve cells that control walking, balance, mobility, vision, speech, and swallowing. Five to six people per 100,000 will develop PSP. CBD affects an estimated 2000-3000 people in United States, of whom only 500-750 are diagnosed.

Mission and tagline reproduced from the source record.

Historical scorecard

Three perspectives. One record.

80.65Overall score
out of 100
73.55Financial score
out of 100
93.00Accountability & transparency
out of 100

These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗

Financial context

Revenue, expenses, and composition

Total revenue · USD$2,704,782
Total expenses · USD$2,357,223

Program expenses

$1,678,342.78 recorded amount
71.2%

Fundraising expenses

$393,656.24 recorded amount
16.7%

Administrative expenses

$280,509.54 recorded amount
11.9%
Fundraising efficiency
$0.16 spent per $1 raised in donations, as defined in the source.

Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗

Historical leadership record

The leadership information supplied

Recorded leader
David Kemp
Recorded compensation
$200,000.00
Recorded compensation percentage
8.48%

These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗

Inspect all 23 original source fields

Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.

All 23 original fields for CurePSP
Source fieldOriginal source value
ascore
Accountability & transparency score
93.0
category
Category
Health
description
Mission & description
CurePSP, Inc. is dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and related brain diseases; advancing research toward cure and prevention; educating healthcare professionals; and providing support, education and hope for affected persons and their families. PSP and CBD are neurodegenerative brain diseases that have no known cause, treatment or cure. They affect nerve cells that control walking, balance, mobility, vision, speech, and swallowing. Five to six people per 100,000 will develop PSP. CBD affects an estimated 2000-3000 people in United States, of whom only 500-750 are diagnosed.
ein
EIN
52-1704978
tot_exp
Total expenses
2357223.0
admin_exp_p
Administrative expense fraction
0.11900000000000001
fund_eff
Fundraising efficiency ($ per $1 raised)
0.16
fund_exp_p
Fundraising expense fraction
0.16699999999999998
program_exp_p
Program expense fraction
0.7120000000000001
fscore
Financial score
73.55
leader
Recorded leader
David Kemp
leader_comp
Recorded leader compensation
200000.0
leader_comp_p
Recorded leader compensation fraction
0.0848
motto
Tagline
because hope matters
name
Charity name
CurePSP
tot_rev
Total revenue
2704782.0
score
Overall score
80.65
state
State code
NY
subcategory
Subcategory
Medical Research
size
Source size label
small
program_exp
Program expenses
1678342.776
fund_exp
Fundraising expenses
393656.241
admin_exp
Administrative expenses
280509.537

Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.